Skip to main content
Top
Published in: Techniques in Coloproctology 10/2020

01-10-2020 | Crohn's Disease | Original Article

Small bowel adenocarcinoma in Crohn’s disease: a rare but devastating complication

Authors: T. Hussain, N. A Jeganathan, G. Karagkounis, L. Stocchi, S. Shawki, S. D. Holubar, I. Gordon, T. Hull, D. Liska

Published in: Techniques in Coloproctology | Issue 10/2020

Login to get access

Abstract

Background

Small bowel adenocarcinoma (SBA) remains a rare entity but occurs at increased frequency in the setting of chronic Crohn’s disease (CD). Our aim was to study the presentation, diagnosis and prognosis of SBA in patients undergoing surgery for CD at a single institution.

Methods

We reviewed the medical records of all patients with CD complicated by adenocarcinoma of the small bowel from 2000 to 2017. Descriptive statistics and Kaplan–Meier overall survival estimates were calculated.

Results

In total, 22 patients (14 males) with CD (median duration of Crohn’s diagnosis 32 years) were diagnosed with SBA and underwent surgical resection (8 isolated small bowel resections, 12 ileocolic resections, and 2 total proctocolectomies). The median patient age at the time of diagnosis was 54 years (range 22–82 years). A total of 17 patients (77%) underwent cross-sectional CT imaging within 3 months of surgery, a cancer diagnosis was suggested in only one patient. In one other patient, SBA was diagnosed preoperatively on endoscopic biopsy of the terminal ileum. The remaining patients were operated on for obstruction (n = 17), abscess or fistulizing disease (n = 2), and sigmoid cancer (n = 1). For these 20 (90%) patients not suspected to have SBA on preoperative assessment, 5 (25%) were diagnosed intraoperatively on frozen section and 15 (75%) were unexpectedly diagnosed postoperatively on final pathology. T staging was characterized by more advanced tumors (T4: 59%, T3: 27%, T2: 9%, and T1: 5%). Nine patients (41%) had nodal involvement and five patients (23%) had hepatic and/or peritoneal carcinomatosis. The 1-, 3-, and 5-year survival estimates for our cohort were 84%, 30%, and 10%, respectively. Median survival was 30.5 months with median follow-up of 23 months (range 6–84 months).

Conclusions

SBA in the setting of CD is most commonly found incidentally after surgical resection for benign indications. As such, any suspicious finding at the time of surgery in a patient with chronic CD should warrant careful investigation with frozen section and/or resection. Prognosis for CD complicated by SBA remains poor even in the modern era.
Literature
1.
go back to reference Ammann R, Bivetti J, Kobler E, Peter P (1977) Gastroenterologisches Röntgenquiz [Gastroenterologic roentgen quiz]. Leber Magen Darm 7(2):91–130PubMed Ammann R, Bivetti J, Kobler E, Peter P (1977) Gastroenterologisches Röntgenquiz [Gastroenterologic roentgen quiz]. Leber Magen Darm 7(2):91–130PubMed
2.
go back to reference Jess T, Winther KV, Munkholm P, Langholz E, Binder V (2004) Intestinal and extraintestinal cancer in Crohn’s disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 19:287–293CrossRef Jess T, Winther KV, Munkholm P, Langholz E, Binder V (2004) Intestinal and extraintestinal cancer in Crohn’s disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 19:287–293CrossRef
3.
go back to reference Ginzburg L, Schneider KM, Dreizin DH et al (1956) Carcinoma of the jejunum occurring in a case of regional enteritis. Surgery 39:347–351PubMed Ginzburg L, Schneider KM, Dreizin DH et al (1956) Carcinoma of the jejunum occurring in a case of regional enteritis. Surgery 39:347–351PubMed
4.
go back to reference Svrcek M, Piton G, Cosnes J, Beaugerie L, Vermeire S, Geboes K, Lemoine A, Cervera P, El-Murr N, Dumont S, Scriva A, Lascols O, Ardizzone S, Fociani P, Savoye G, Le Pessot F, Novacek G, Wrba F, Colombel JF, Leteurtre E, Bouhnik Y, Cazals-Hatem D, Cadiot G, Diebold MD, Rahier JF, Delos M, Flejou JF, Carbonnel F (2014) Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study. Inflamm Bowel Dis 20:1584–1592CrossRef Svrcek M, Piton G, Cosnes J, Beaugerie L, Vermeire S, Geboes K, Lemoine A, Cervera P, El-Murr N, Dumont S, Scriva A, Lascols O, Ardizzone S, Fociani P, Savoye G, Le Pessot F, Novacek G, Wrba F, Colombel JF, Leteurtre E, Bouhnik Y, Cazals-Hatem D, Cadiot G, Diebold MD, Rahier JF, Delos M, Flejou JF, Carbonnel F (2014) Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study. Inflamm Bowel Dis 20:1584–1592CrossRef
5.
go back to reference Liao X, Li G, McBride R, Houldsworth J, Harpaz N, Polydorides AD (2019) Clinicopathological and molecular characterization of Crohn's disease-associated small bowel adenocarcinomas. J Crohns Colitis 14:287CrossRef Liao X, Li G, McBride R, Houldsworth J, Harpaz N, Polydorides AD (2019) Clinicopathological and molecular characterization of Crohn's disease-associated small bowel adenocarcinomas. J Crohns Colitis 14:287CrossRef
6.
go back to reference Shaukat A, Virnig DJ, Howard D, Sitaraman SV, Liff JM, Lederle FA (2011) Crohn’s disease and small bowel adenocarcinoma: a population-based case-control study. Cancer Epidemiol Biomark Prev 20:1120–1123CrossRef Shaukat A, Virnig DJ, Howard D, Sitaraman SV, Liff JM, Lederle FA (2011) Crohn’s disease and small bowel adenocarcinoma: a population-based case-control study. Cancer Epidemiol Biomark Prev 20:1120–1123CrossRef
7.
go back to reference Hutchins RR, Hani AB, Kojodjojo P et al (2001) Adenocarcinoma of the small bowel. ANZ J Surg 71:428–437CrossRef Hutchins RR, Hani AB, Kojodjojo P et al (2001) Adenocarcinoma of the small bowel. ANZ J Surg 71:428–437CrossRef
8.
go back to reference Bilimoria KY, Bentrem DJ, Wayne JD et al (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249:63–71CrossRef Bilimoria KY, Bentrem DJ, Wayne JD et al (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249:63–71CrossRef
9.
go back to reference Greenstein AJ (2000) Cancer in inflammatory bowel disease. Mt Sinai J Med 67:227–240PubMed Greenstein AJ (2000) Cancer in inflammatory bowel disease. Mt Sinai J Med 67:227–240PubMed
10.
go back to reference Weber NK, Fletcher JG, Fidler JL et al (2015) Clinical characteristics and imaging features of small bowel adenocarcinomas in Crohn's disease. Abdom Imaging 40(5):1060–1067CrossRef Weber NK, Fletcher JG, Fidler JL et al (2015) Clinical characteristics and imaging features of small bowel adenocarcinomas in Crohn's disease. Abdom Imaging 40(5):1060–1067CrossRef
11.
go back to reference Buckley JA, Siegelman SS, Jones B, Fishman EK (1997) The accuracy of CT staging of small bowel adenocarcinoma: CT/pathologic correlation. J Comput Assist Tomogr 17(21):986–991CrossRef Buckley JA, Siegelman SS, Jones B, Fishman EK (1997) The accuracy of CT staging of small bowel adenocarcinoma: CT/pathologic correlation. J Comput Assist Tomogr 17(21):986–991CrossRef
12.
go back to reference Engin G (2008) Computed tomography enteroclysis in the diagnosis of intestinal diseases. J Comput Assist Tomogr 32:9–16CrossRef Engin G (2008) Computed tomography enteroclysis in the diagnosis of intestinal diseases. J Comput Assist Tomogr 32:9–16CrossRef
13.
go back to reference Ikeuchi H, Nakano H, Uchino M, Nakamura M, Matsuoka H, Fukuda Y, Matsumoto T, Takesue Y, Tomita N (2008) Intestinal cancer in Crohn’s disease. Hepatogastroenterology 55:2121–2124PubMed Ikeuchi H, Nakano H, Uchino M, Nakamura M, Matsuoka H, Fukuda Y, Matsumoto T, Takesue Y, Tomita N (2008) Intestinal cancer in Crohn’s disease. Hepatogastroenterology 55:2121–2124PubMed
14.
go back to reference Kodaira C, Osawa S, Mochizuki C, Sato Y, Nishino M, Yamada T, Takayanagi Y, Takagaki K, Sugimoto K, Kanaoka S, Furuta T, Ikuma M (2009) A case of small bowel adenocarcinoma in a patient with Crohn’s disease detected by PET/CT and double-balloon enteroscopy. World J Gastroenterol 15:1774–1778CrossRef Kodaira C, Osawa S, Mochizuki C, Sato Y, Nishino M, Yamada T, Takayanagi Y, Takagaki K, Sugimoto K, Kanaoka S, Furuta T, Ikuma M (2009) A case of small bowel adenocarcinoma in a patient with Crohn’s disease detected by PET/CT and double-balloon enteroscopy. World J Gastroenterol 15:1774–1778CrossRef
15.
go back to reference Van Weyenberg SJ, Bouman K, Jacobs MA, Halloran BP, Cahill C et al (2014) Small bowel adenocarcinoma in Crohn’s disease. WJG 20(33):11494. https://www.wjgnet.com. Accessed 07 Sept 2014 Van Weyenberg SJ, Bouman K, Jacobs MA, Halloran BP, Cahill C et al (2014) Small bowel adenocarcinoma in Crohn’s disease. WJG 20(33):11494. https://​www.​wjgnet.​com. Accessed 07 Sept 2014
16.
go back to reference Kerber GW, Frank PH (1984) Carcinoma of the small intestine and colon as a complication of Crohn disease: radiologic manifestations. Radiology 150:639–645CrossRef Kerber GW, Frank PH (1984) Carcinoma of the small intestine and colon as a complication of Crohn disease: radiologic manifestations. Radiology 150:639–645CrossRef
17.
go back to reference Palascak-Juif V, Bouvier AM, Cosnes J et al (2005) Small bowel adenocarcinoma inpatients with Crohn’s disease compared with small bowel adenocarcinoma de novo. Inflamm Bowel Dis 11:828–832CrossRef Palascak-Juif V, Bouvier AM, Cosnes J et al (2005) Small bowel adenocarcinoma inpatients with Crohn’s disease compared with small bowel adenocarcinoma de novo. Inflamm Bowel Dis 11:828–832CrossRef
18.
go back to reference Michelassi F, Testa G, Pomidor WJ et al (1993) Adenocarcinoma complicating Crohn’s disease. Dis Colon Rectum 36:654–661CrossRef Michelassi F, Testa G, Pomidor WJ et al (1993) Adenocarcinoma complicating Crohn’s disease. Dis Colon Rectum 36:654–661CrossRef
19.
go back to reference Lashner BA (1992) Risk factors for small bowel cancer in Crohn’s disease. Dig Dis Sci 37:1179–1184CrossRef Lashner BA (1992) Risk factors for small bowel cancer in Crohn’s disease. Dig Dis Sci 37:1179–1184CrossRef
20.
go back to reference Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther 23:1097–1104CrossRef Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther 23:1097–1104CrossRef
21.
go back to reference Solem CA, Harmsen WS, Zinsmeister AR et al (2004) Small intestinal adenocarcinoma in Crohn’s disease: a case-control study. Inflamm Bowel Dis 10(32–35):18 Solem CA, Harmsen WS, Zinsmeister AR et al (2004) Small intestinal adenocarcinoma in Crohn’s disease: a case-control study. Inflamm Bowel Dis 10(32–35):18
22.
go back to reference Singh K, Singh A, Philpott J, Liska D, Lai K (2019) Occult Adenocarcinoma Arising in Crohn’s-related 18 strictures: a case series. Crohn's Colitis 360(1):3 Singh K, Singh A, Philpott J, Liska D, Lai K (2019) Occult Adenocarcinoma Arising in Crohn’s-related 18 strictures: a case series. Crohn's Colitis 360(1):3
23.
go back to reference Scott KW, Grace RH (1989) Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 76(11):1165–1167CrossRef Scott KW, Grace RH (1989) Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 76(11):1165–1167CrossRef
24.
go back to reference Cianchi F, Palomba A, Boddi V et al (2002) Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 26(3):384–389CrossRef Cianchi F, Palomba A, Boddi V et al (2002) Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 26(3):384–389CrossRef
25.
go back to reference Benson AB 3rd, Schrag D, Somerfield MR et al (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22(16):3408–3419CrossRef Benson AB 3rd, Schrag D, Somerfield MR et al (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22(16):3408–3419CrossRef
26.
go back to reference Coffey CJ, Kiernan MG, Sahebally SM et al (2018) Inclusion of the mesentery in ileocolic resection for Crohn's disease is associated with reduced surgical recurrence. J Crohns Colitis 12(10):1139–1150CrossRef Coffey CJ, Kiernan MG, Sahebally SM et al (2018) Inclusion of the mesentery in ileocolic resection for Crohn's disease is associated with reduced surgical recurrence. J Crohns Colitis 12(10):1139–1150CrossRef
27.
go back to reference Kelsey CR, Nelson JW, Willett CG et al (2007) Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. Int J Radiat Oncol Biol Phys 69:1436–1441CrossRef Kelsey CR, Nelson JW, Willett CG et al (2007) Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. Int J Radiat Oncol Biol Phys 69:1436–1441CrossRef
28.
go back to reference Swartz MJ, Hughes MA, Frassica DA et al (2007) Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg 142:285–288CrossRef Swartz MJ, Hughes MA, Frassica DA et al (2007) Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg 142:285–288CrossRef
29.
go back to reference Widmar M, Greenstein AJ, Sachar DB, Harpaz N, Bauer JJ, Greenstein AJ (2011) Small bowel adenocarcinoma in Crohn’s disease. J Gastrointest Surg 15:797–802CrossRef Widmar M, Greenstein AJ, Sachar DB, Harpaz N, Bauer JJ, Greenstein AJ (2011) Small bowel adenocarcinoma in Crohn’s disease. J Gastrointest Surg 15:797–802CrossRef
30.
go back to reference de van Buck OA, Wolthuis A, D’Hoore A (2012) Surgery for Crohn’s disease in the era of biologicals: a reduced need or delayed verdict? World J Gastroenterol 18:3828–3832CrossRef de van Buck OA, Wolthuis A, D’Hoore A (2012) Surgery for Crohn’s disease in the era of biologicals: a reduced need or delayed verdict? World J Gastroenterol 18:3828–3832CrossRef
31.
go back to reference Greenstein A (1995) Malignancy in Crohn’s disease. Perspect Colon Rectal Surg 8:137–159 Greenstein A (1995) Malignancy in Crohn’s disease. Perspect Colon Rectal Surg 8:137–159
32.
go back to reference Dossett LA, White LM, Welch DC, Herline AJ, Muldoon RL, Schwartz DA, Wise PE (2007) Small bowel adenocarcinoma complicating Crohn’s disease: case series and review of the literature. Am Surg 73:1181–1187CrossRef Dossett LA, White LM, Welch DC, Herline AJ, Muldoon RL, Schwartz DA, Wise PE (2007) Small bowel adenocarcinoma complicating Crohn’s disease: case series and review of the literature. Am Surg 73:1181–1187CrossRef
33.
go back to reference Richards ME, Rickert RR, Nance FC (1989) Crohn’s disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease. Ann Surg 209:764–773CrossRef Richards ME, Rickert RR, Nance FC (1989) Crohn’s disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease. Ann Surg 209:764–773CrossRef
34.
go back to reference Michelassi F, Testa G, Pomidor WJ, Lashner BA, Block GE (1993) Adenocarcinoma complicating Crohn’s disease. Dis Colon Rectum 36:654–661CrossRef Michelassi F, Testa G, Pomidor WJ, Lashner BA, Block GE (1993) Adenocarcinoma complicating Crohn’s disease. Dis Colon Rectum 36:654–661CrossRef
35.
go back to reference Fishman PN, Pond GR, Moore MJ, Oza A, Burkes RL, Siu LL, Feld R, Gallinger S, Greig P, Knox JJ (2006) Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol 29:225–231CrossRef Fishman PN, Pond GR, Moore MJ, Oza A, Burkes RL, Siu LL, Feld R, Gallinger S, Greig P, Knox JJ (2006) Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol 29:225–231CrossRef
36.
go back to reference Collier PE, Turowski P, Diamond DL (1985) Small intestinal adenocarcinoma complicating regional enteritis. Cancer 55:516–521CrossRef Collier PE, Turowski P, Diamond DL (1985) Small intestinal adenocarcinoma complicating regional enteritis. Cancer 55:516–521CrossRef
37.
go back to reference Meryn S, Lochs H (1983) Diagnostic usefulness of plasma carcinoembryonic antigen (CEA) levels in Crohn’s disease. Dig Dis Sci 28:478–479CrossRef Meryn S, Lochs H (1983) Diagnostic usefulness of plasma carcinoembryonic antigen (CEA) levels in Crohn’s disease. Dig Dis Sci 28:478–479CrossRef
Metadata
Title
Small bowel adenocarcinoma in Crohn’s disease: a rare but devastating complication
Authors
T. Hussain
N. A Jeganathan
G. Karagkounis
L. Stocchi
S. Shawki
S. D. Holubar
I. Gordon
T. Hull
D. Liska
Publication date
01-10-2020
Publisher
Springer International Publishing
Published in
Techniques in Coloproctology / Issue 10/2020
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-020-02269-8

Other articles of this Issue 10/2020

Techniques in Coloproctology 10/2020 Go to the issue